Qui sommes-nous ?
L'ANSM en bref
Nos engagements
Nos missions
Notre périmètre
Notre organisation
Déontologie et transparence
Publications institutionnelles
Publications scientifiques
Rejoignez-nous !
Notre agenda
 
Actualités
Nos articles
Nos campagnes
 
Bulletin officiel des actes, décisions et avis
Décisions institutionnelles
Décisions liées aux médicaments
Décisions liées aux produits sanguins et autres produits biologiques
Décisions liées aux médicaments dérivés du plasma
Décisions liées aux dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Injonctions
Décisions de police sanitaire
Sanctions financières
Avis
 
Disponibilité des produits de santé
Médicaments
Dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Vaccins
 
Vos démarches
Industriel
Organismes notifiés
Professionnel de santé
Patient
Chercheur

Our scope of action

A+ A-
ANSM’s scope of action covers the different categories of medicines (proprietary, generic, biosimilar, herbal, homoeopathic medicines, etc.) available on the market for adults and the paediatric population.

In the development of a medicine, ANSM is involved from the clinical trial phase. It subsequently grants, on a national level, a marketing authorisation (MA) based on the assessment of the benefits and risks of the medicine, and continues to conduct surveillance of its safety of use. Finally, ANSM has control over the advertising for these health products aimed at the public and healthcare professionals.

In the pages below, you will find definitions and general information on the different types of medicines, apart from  vaccines, which are covered in their own separate section.
 

Herbal medicines and essential oils

What are herbal medicines ?

A herbal medicine is a medicine for which the active substance is exclusively one or more herbal substances, a plant-based preparation, or a combination of several herbal substances or plant-based preparations.
(Art. L. 5121-1, Paragraph 16 French Public Health Code)

It may take the form of a pharmaceutical product, a pharmaceutical preparation (pharmacy-compounded or pharmacy-prepared), or a herbal drug.

Herbal medicines in pharmaceutical product form

A pharmaceutical product is a medicine that has been prepared in advance, is presented in specific packaging, and characterised by a specific name.

A herbal pharmaceutical product is a medicine in which the active substance is of plant origin, i.e. manufactured from one or more plants.
The active substance may be concentrated, e.g. in extract form, manufactured from a part of the plant (leaves, root, etc.), or from the whole plant.

Its release to the French market is subject to the granting of a marketing authorisation (MA) or registration by ANSM.

Herbal medicines in pharmacy-compounded or pharmacy-prepared preparations

Preparations are medicines prepared in pharmacies for the specific needs of one or more patients.
There are two different types of preparations made from medicinal herbs, extracts or essential oils.

Pharmacy-compounded preparation : prepared for a specific patient according to a medical prescription, due to the lack of an available or suitable product. They are prepared by a community pharmacy or by an in-house pharmacy (PUI) of a healthcare institution.

Pharmacy-prepared preparations : these preparations are included in the pharmacopoeia or national formulary, and are prepared in community pharmacies to be dispensed directly to the pharmacies’ patients.

Specific case: herbal teas

Community pharmacies may prepare herbal tea blends in the form of pharmacy-prepared preparations, according to the conditions set out in the national formulary monograph.

All preparations – whether pharmacy-compounded or pharmacy-prepared – are produced and dispensed under a pharmacist’s responsibility in accordance with Good Preparation Practice.
 
View the National Formulary monograph
All preparations – whether pharmacy-compounded or pharmacy-prepared – are produced and dispensed under a pharmacist’s responsibility in accordance with Good Preparation Practice.
 
Find out more about hospital-prepared, pharmacy-compounded and pharmacy-prepared preparations
Key messages
A blend of medicinal herbs has a preparation status.
Medicinal herbs sold in bulk are not preparations.

Herbal drugs

Herbal drugs are medicinal herbs, aromatics and their derivatives, which is dispensed in bulk, as is or in the form of preparations (extracts or essential oils).
They may be used whole or in plant part form and have medicinal properties. 

The French Pharmacopoeia specifies that they may also be used in food, as condiments, or for hygiene purposes.

Where can herbal medicines be obtained ?

Herbal medicines, like all other medicines, are dispensed by community pharmacies, or on registered pharmacy dispensary websites.

Medicinal herbs may be used for manufacturing medicines, but may also be dispensed in bulk or in the form of pharmaceutical preparations by pharmacy dispensaries.

Some medicinal herbs having a therapeutic use are identified in the list published in the French Pharmacopoeia, and are reserved for sale in pharmacies : the sale of medicinal herbs listed in the French Pharmacopeia is reserved for pharmacists, subject to exemptions set out by order (Art L.4211-1 Paragraph 5 of the French Public Health Code)
 
Find out more about substances of plant origin

Medicines and the Internet

Due to their nature and status, herbal medicines are particularly exposed to counterfeiting risks.

Essential oils

What are essential oils ?

Essential oils are deemed to be herbal “preparations”. (Article R5121 of the French Public Health Code)
 
They are defined as “odorous products, usually of complex composition, obtained from a botanically defined plant raw material by steam distillation, dry distillation, or a suitable mechanical process without heating.
  • Essential oils are most often separated from aqueous phase by a physical process that does not cause a significant change in its composition” (European Pharmacopoeia definition).
  • Depending on their use and claims, essential oils are subject to cosmetic product, biocide (sanitising sprays), or herbal medicine regulations.
  • An essential oil is deemed to be a medicine if it is described as having properties for treating or preventing human diseases, or when it has a pharmacological, immunological, or metabolic action.
  • It may also be used as an excipient (e.g. aroma) in the formula of a medicine.
  • In pharmacies, essential oils may be dispensed in the form of pharmacy-compounded preparations or as is.

How can essential oils be used safely ?

The active substances in essential oils may give rise to a risk of serious adverse reactions following inappropriate and uncontrolled use.
It is recommended to ask the pharmacist for advice
  • prior medical advice is required for the use of essential oils for pregnant women and for children, particularly when they are used orally ;
  • essential oils pose an increased risk of toxicity if misused: follow the instructions for use ;
  • essential oils must not be used for prolonged periods (beyond a few days) without medical advice ;
  • if no improvement is observed after a few days of use, seek medical advice.

Essential oils for which sales are restricted to pharmacies

Essential oils dispensed only in pharmacies must comply with the pharmaceutical quality described in the European Pharmacopeia or in the French Pharmacopoeia. This reference describes the exact scientific name of the essential oil, its chemotype where applicable, and its chemical composition.

These fifteen essential oils are identified as having a negative benefit-risk ratio

It is preferable not to dispense them. They are only available in the pharmaceutical circuit due to their neurotoxic (wormwood, arborvitae, common sage), irritant (common saving, mustard), phototoxic (rue) or carcinogenic (sassafras) properties:
  • Common Wormwood (Artemisia absinthium  L.)
  • Roman Wormwood (Artemisia pontica L.)
  • Mugwort (Artemisia vulgaris L.)
  • White Wormwood (Artemisia herba alba  Asso L.)
  • Tree Wormwood (Artemisia arborescens L.)
  • Arborvitae or Northern White-Cedar (Thuya occidentalis L.)
  • Korean Arborvitae (Thuya Koraenensis  Nakai), or “Cedar Leaf”
  • Hyssop (Hyssopus officinalis L.)
  • Common Sage (Salvia officinalis L.)
  • Tansy (Tanacetum vulgare L.) Western Red Cedar (Thuya plicata  Donn ex D. Don.)
  • Sassafras (Sassafras albidum  [Nutt.] Nees)
  • Common Savin (Juniperus sabina L.)
  • Rue (Ruta graveolens L.)
  • Mexican Tea (Chenopodium ambrosioides and Chenopodium anthelminticum  L.)
  • Mustard Greens (Brassica juncea  [L.] Czernj. et Cosson).
 
View Decree No. 2007-1198 of 3 August 2007

Essential oils not restricted to the pharmaceutical circuit

Essentials oils which are not restricted to the pharmaceutical circuit are available over-the-counter, and distributed by various circuits (pharmacist, specialist retail outlets, etc.).
They must not claim any therapeutic indications insofar as their composition is not guaranteed with regard to their potential therapeutic effect.

The online sale of medicines is regulated. To find out more, refer to the file on “Online sale of medicines”.